A citation-based method for searching scientific literature

Marianne F Weber, Henry M Marshall, Nicole Rankin, Stephen Duffy, Kwun M Fong, Kate Dunlop, Lauren Humphries, Amelia K Smit, Anne E Cust, Natalie Taylor, Gillian Mitchell, Yoon-Jung Kang, Kathy Tucker, Mark Jenkins, Finlay Macrae, Ian Lockart, Mark Danta, Bruce K Armstrong, Megan Howe. Public Health Res Pract 2019
Times Cited: 4







List of co-cited articles
4 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda.
Enola Proctor, Hiie Silmere, Ramesh Raghavan, Peter Hovmand, Greg Aarons, Alicia Bunger, Richard Griffey, Melissa Hensley. Adm Policy Ment Health 2011
50

Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework.
Mandeep Sekhon, Martin Cartwright, Jill J Francis. BMC Health Serv Res 2017
707
50


Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility.
Maria Teresa Landi, D Timothy Bishop, Stuart MacGregor, Mitchell J Machiela, Alexander J Stratigos, Paola Ghiorzo, Myriam Brossard, Donato Calista, Jiyeon Choi, Maria Concetta Fargnoli,[...]. Nat Genet 2020
48
50

Personalized early detection and prevention of breast cancer: ENVISION consensus statement.
Nora Pashayan, Antonis C Antoniou, Urska Ivanus, Laura J Esserman, Douglas F Easton, David French, Gaby Sroczynski, Per Hall, Jack Cuzick, D Gareth Evans,[...]. Nat Rev Clin Oncol 2020
67
25

Acceptability of risk-stratified population screening across cancer types: Qualitative interviews with the Australian public.
Kate Dunlop, Nicole M Rankin, Amelia K Smit, Zofia Salgado, Ainsley J Newson, Louise Keogh, Anne E Cust. Health Expect 2021
3
33

Population-Based Precision Cancer Screening: A Symposium on Evidence, Epidemiology, and Next Steps.
Pamela M Marcus, Nora Pashayan, Timothy R Church, V Paul Doria-Rose, Michael K Gould, Rebecca A Hubbard, Michael Marrone, Diana L Miglioretti, Paul D Pharoah, Paul F Pinsky,[...]. Cancer Epidemiol Biomarkers Prev 2016
37
25

The use of a risk assessment and decision support tool (CRISP) compared with usual care in general practice to increase risk-stratified colorectal cancer screening: study protocol for a randomised controlled trial.
Jennifer G Walker, Finlay Macrae, Ingrid Winship, Jasmeen Oberoi, Sibel Saya, Shakira Milton, Adrian Bickerstaffe, James G Dowty, Richard De Abreu Lourenço, Malcolm Clark,[...]. Trials 2018
7
25

The CRISP-Q study: Communicating the risks and benefits of colorectal cancer screening
Grace Y Kim, Jennifer G Walker, Adrian Bickerstaffe, Nadira Hewabandu, Marie Pirotta, Louisa Flander, Mark Jenkins, Jon D Emery. Aust J Gen Pract 2018
9
25



European women's perceptions of the implementation and organisation of risk-based breast cancer screening and prevention: a qualitative study.
Linda Rainey, Daniëlle van der Waal, Anna Jervaeus, Louise S Donnelly, D Gareth Evans, Mattias Hammarström, Per Hall, Yvonne Wengström, Mireille J M Broeders. BMC Cancer 2020
9
25

Effect of interventions including provision of personalised cancer risk information on accuracy of risk perception and psychological responses: A systematic review and meta-analysis.
Max Bayne, Madi Fairey, Barbora Silarova, Simon J Griffin, Stephen J Sharp, William M P Klein, Stephen Sutton, Juliet A Usher-Smith. Patient Educ Couns 2020
5
25

Identification of cancer risk and associated behaviour: implications for social marketing campaigns for cancer prevention.
Rebecca Kippen, Erica James, Bernadette Ward, Penny Buykx, Ardel Shamsullah, Wendy Watson, Kathy Chapman. BMC Cancer 2017
9
25

Consumer and clinician perspectives on personalising breast cancer prevention information.
L A Keogh, E Steel, P Weideman, P Butow, I M Collins, J D Emery, G B Mann, A Bickerstaffe, A H Trainer, L J Hopper,[...]. Breast 2019
12
25

Should women aged 70-74 be invited to participate in screening mammography? A report on two Australian community juries.
Chris Degeling, Alexandra Barratt, Sanchia Aranda, Robin Bell, Jenny Doust, Nehmat Houssami, Jolyn Hersch, Ruben Sakowsky, Vikki Entwistle, Stacy M Carter. BMJ Open 2018
9
25

Resisting Moralisation in Health Promotion.
Rebecca C H Brown. Ethical Theory Moral Pract 2018
15
25


Toward the implementation of genomic applications for smoking cessation and smoking-related diseases.
Alex T Ramsey, Li-Shiun Chen, Sarah M Hartz, Nancy L Saccone, Sherri L Fisher, Enola K Proctor, Laura J Bierut. Transl Behav Med 2018
8
25

Public interest in and acceptability of the prospect of risk-stratified screening for breast and prostate cancer.
Marie Koitsalu, Mirjam A G Sprangers, Martin Eklund, Kamila Czene, Per Hall, Henrik Grönberg, Yvonne Brandberg. Acta Oncol 2016
26
25

Impact of news of celebrity illness on breast cancer screening: Kylie Minogue's breast cancer diagnosis.
Simon Chapman, Kim McLeod, Melanie Wakefield, Simon Holding. Med J Aust 2005
128
25

Personalized medicine for prevention: can risk stratified screening decrease colorectal cancer mortality at an acceptable cost?
Sujha Subramanian, Georgiy Bobashev, Robert J Morris, Sonja Hoover. Cancer Causes Control 2017
12
25

Early detection of melanoma: a consensus report from the Australian Skin and Skin Cancer Research Centre Melanoma Screening Summit.
Monika Janda, Anne E Cust, Rachel E Neale, Joanne F Aitken, Peter D Baade, Adele C Green, Kiarash Khosrotehrani, Victoria Mar, H Peter Soyer, David C Whiteman. Aust N Z J Public Health 2020
13
25

Genetic testing and personalized ovarian cancer screening: a survey of public attitudes.
Susanne F Meisel, Belinda Rahman, Lucy Side, Lindsay Fraser, Sue Gessler, Anne Lanceley, Jane Wardle. BMC Womens Health 2016
20
25

Implementation considerations for offering personal genomic risk information to the public: a qualitative study.
Amelia K Smit, Gillian Reyes-Marcelino, Louise Keogh, Kate Dunlop, Ainsley J Newson, Anne E Cust. BMC Public Health 2020
5
25

The melanoma genomics managing your risk study: A protocol for a randomized controlled trial evaluating the impact of personal genomic risk information on skin cancer prevention behaviors.
Amelia K Smit, Ainsley J Newson, Rachael L Morton, Michael Kimlin, Louise Keogh, Matthew H Law, Judy Kirk, Suzanne Dobbinson, Peter A Kanetsky, Georgina Fenton,[...]. Contemp Clin Trials 2018
10
25

Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model.
Nora Pashayan, Steve Morris, Fiona J Gilbert, Paul D P Pharoah. JAMA Oncol 2018
125
25

A response to "Personalised medicine and population health: breast and ovarian cancer".
Antonis Antoniou, Hoda Anton-Culver, Alexander Borowsky, Mireille Broeders, Jennifer Brooks, Anna Chiarelli, Jocelyne Chiquette, Jack Cuzick, Suzette Delaloge, Peter Devilee,[...]. Hum Genet 2019
11
25

Stratified cancer screening: the practicalities of implementation.
T Dent, J Jbilou, I Rafi, N Segnan, S Törnberg, S Chowdhury, A Hall, G Lyratzopoulos, R Eeles, D Eccles,[...]. Public Health Genomics 2013
38
25

Communicating genetic risk information for common disorders in the era of genomic medicine.
Denise M Lautenbach, Kurt D Christensen, Jeffrey A Sparks, Robert C Green. Annu Rev Genomics Hum Genet 2013
91
25


Protocol and Rationale for the International Lung Screening Trial.
Kuan Pin Lim, Henry Marshall, Martin Tammemägi, Fraser Brims, Annette McWilliams, Emily Stone, Renee Manser, Karen Canfell, Marianne Weber, Luke Connelly,[...]. Ann Am Thorac Soc 2020
23
25


Women's perceptions of the adoption of personalised risk-based breast cancer screening and primary prevention: a systematic review.
Linda Rainey, Daniëlle van der Waal, Yvonne Wengström, Anna Jervaeus, Mireille J M Broeders. Acta Oncol 2018
14
25

Risk-based breast cancer screening strategies in women.
Elaine F Harkness, Susan M Astley, D Gareth Evans. Best Pract Res Clin Obstet Gynaecol 2020
18
25

Women's decision-making regarding risk-stratified breast cancer screening and prevention from the perspective of international healthcare professionals.
Linda Rainey, Daniëlle van der Waal, Louise S Donnelly, D Gareth Evans, Yvonne Wengström, Mireille Broeders. PLoS One 2018
18
25

"A Natural Progression": Australian Women's Attitudes About an Individualized Breast Screening Model.
Jocelyn Lippey, Louise A Keogh, G Bruce Mann, Ian G Campbell, Laura E Forrest. Cancer Prev Res (Phila) 2019
13
25

Public Awareness and Perceptions of Colorectal Cancer Prevention: a Cross-Sectional Survey.
Markus Dines Knudsen, Geir Hoff, Ida Tidemann-Andersen, Gry Ekeberg Bodin, Sissel Øvervold, Paula Berstad. J Cancer Educ 2021
4
25

Adjusting the frequency of mammography screening on the basis of genetic risk: Attitudes among women in the UK.
Susanne F Meisel, Nora Pashayan, Belinda Rahman, Lucy Side, Lindsay Fraser, Sue Gessler, Anne Lanceley, Jane Wardle. Breast 2015
35
25

Distress, uncertainty, and positive experiences associated with receiving information on personal genomic risk of melanoma.
Amelia K Smit, Ainsley J Newson, Megan Best, Caro-Anne Badcock, Phyllis N Butow, Judy Kirk, Kate Dunlop, Georgina Fenton, Anne E Cust. Eur J Hum Genet 2018
15
25

Acceptability and potential impact on uptake of using different risk stratification approaches to determine eligibility for screening: A population-based survey.
Juliet A Usher-Smith, Laragh L W Harvey-Kelly, Sabrina H Rossi, Hannah Harrison, Simon J Griffin, Grant D Stewart. Health Expect 2021
6
25

What is overdiagnosis and why should we take it seriously in cancer screening?
Stacy M Carter, Alexandra Barratt. Public Health Res Pract 2017
21
25

Association analyses identify 31 new risk loci for colorectal cancer susceptibility.
Philip J Law, Maria Timofeeva, Ceres Fernandez-Rozadilla, Peter Broderick, James Studd, Juan Fernandez-Tajes, Susan Farrington, Victoria Svinti, Claire Palles, Giulia Orlando,[...]. Nat Commun 2019
93
25

GP attitudes to and expectations for providing personal genomic risk information to the public: a qualitative study.
Amelia K Smit, Ainsley J Newson, Louise Keogh, Megan Best, Kate Dunlop, Kylie Vuong, Judy Kirk, Phyllis Butow, Lyndal Trevena, Anne E Cust. BJGP Open 2019
7
25

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.
Kyriaki Michailidou, Jonathan Beesley, Sara Lindstrom, Sander Canisius, Joe Dennis, Michael J Lush, Mel J Maranian, Manjeet K Bolla, Qin Wang, Mitul Shah,[...]. Nat Genet 2015
368
25

Validation of a scale for assessing attitudes towards outcomes of genetic cancer testing among primary care providers and breast specialists.
Anne-Deborah Bouhnik, Khadim N'Diaye, D Gareth Evans, Hilary Harris, Aad Tibben, Christi van Asperen, Joerg Schmidtke, Irmgard Nippert, Julien Mancini, Claire Julian-Reynier. PLoS One 2017
4
25

Preparing Medical Specialists to Practice Genomic Medicine: Education an Essential Part of a Broader Strategy.
Erin Crellin, Belinda McClaren, Amy Nisselle, Stephanie Best, Clara Gaff, Sylvia Metcalfe. Front Genet 2019
28
25

The personal and clinical utility of polygenic risk scores.
Ali Torkamani, Nathan E Wineinger, Eric J Topol. Nat Rev Genet 2018
538
25

The emerging field of polygenic risk scores and perspective for use in clinical care.
Tatiane Yanes, Aideen M McInerney-Leo, Matthew H Law, Shelly Cummings. Hum Mol Genet 2020
18
25



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.